Menu
Sign In Pricing Add Podcast

BackTable Urology

Ep. 193 Bladder Cancer Innovations: ESMO 2024 Highlights with Dr. Andrea Apolo

1616.812 - 1639.87 Dr. Bogdana Schmidt

So now to just put a point on what you just made. So let's say you have a patient who refused cisplatin up front, not, you know, didn't get Niagara Protocol. Post-op, would you still be trying to engage in chemo or checkpoint if they're eligible but refused? Would you be trying to tackle that refusal for the second time or no?

0
💬 0

Comments

There are no comments yet.

Log in to comment.